EIC Summit 25 Networking Platform

2–3 Apr 2025 | Brussels, Belgium

InvestmentUpdated on 2 April 2025

Investment round

Marja Tiirola

CSO at Biopsense Oy

Jyväskylä, Keski-Suomi, Finland

About

We search resources for 1) clinical validation (IVDR class A); 2) for setting up the first line of large-scale manufacturing; and 3) scaling the production of BiopSense technology from cfDNA to miRNA processing. Will broaden our markets from cancer to neurological and mental disorders.

Stage

  • Speed and Development
  • Startup

Applies to

  • Medical Technologies

Organisation

Biopsense Oy

Start-ups and SMEs

Jyväskylä, Finland

Similar opportunities